Our Low GI Soba Noodles are scientifically engineered for health-conscious consumers, specifically those managing blood sugar levels. Utilizing a national invention patent, these noodles integrate a potent blend of 70% buckwheat, konjac, and green barley, combined with tartary buckwheat to create a nutritional powerhouse that actively blocks sugar sources and minimizes glycemic spikes.
Backed by rigorous clinical trials conducted with Shanxi Medical University and certified by the Beijing Institute of Nutrition Source, our soba is officially recognized as a low GI food with a verified GI value of 42.7. It provides a high-fiber, high-satiety alternative for individuals with "three highs," those on fat-reduction journeys, or anyone seeking a professional-grade diet for glucose stabilization.
Detailed Parameters
| Glycemic Index (GI) | 42.7 (Certified Low GI) | Buckwheat Content | 70% Premium Blend |
|---|---|---|---|
| Core Ingredients | Buckwheat, Konjac, Green Barley | Special Additives | Tartary Buckwheat |
| Certification | State-issued Low GI Certificate | Clinical Validation | Shanxi Medical University Trials |
| Testing Authority | Beijing Institute of Nutrition Source | Patent Status | National Invention Patent |
| Health Focus | Blood Sugar Stabilization | Dietary Profile | High Fiber / Low Calorie |
Key Advantages
Patented Sugar Block
Utilizes a national invention patent to block sugar sources, ensuring a low glycemic rise after consumption.
Clinically Proven
Three-month clinical trials with diabetic patients prove the product's effectiveness in stabilizing blood sugar.
Certified Low GI
Officially certified by the Beijing Institute of Nutrition Source with a precise GI value of 42.7.
Rich Nutritional Blend
A sophisticated mix of konjac and tartary buckwheat providing essential minerals and vitamins.
High Satiety Index
Dense dietary fiber ensures you feel full longer, making it ideal for weight loss and calorie control.
Broad Health Support
Specifically designed for people with chronic "three highs," sub-health conditions, and glucose needs.
Product Gallery
Management Platforms
Quality Sourcing
Strict selection of 70% buckwheat and premium konjac for consistency.
Patented Processing
Advanced technology applied to ensure low glycemic response in every batch.
Clinical Monitoring
Ongoing partnerships with medical universities for health efficacy tracking.
Certification Audit
Regular audits by the Beijing Institute of Nutrition to maintain GI standards.
Supply Chain Trust
Reliable logistics for food-grade delivery to healthcare and retail sectors.
User Feedback Loop
Collaborating with community doctors to refine taste and health outcomes.
Investment Return Comparison
| Feature | Standard Soba | Our Low GI Soba |
|---|---|---|
| GI Value | High/Medium | 42.7 (Low) |
| Blood Sugar Impact | Rapid Spike | Slow/Stable Rise |
| Scientific Basis | General Nutrition | National Patent & Clinical Trial |
| Dietary Fiber | Standard | Ultra-High Satiety |
| Target Group | General Public | Diabetics & Health-Conscious |
Frequently Asked Questions
These noodles use a patented combination of 70% buckwheat, konjac, and green barley, which naturally slows down the digestion of carbohydrates and prevents rapid spikes in blood glucose.
Yes, they have undergone clinical trials with Shanxi Medical University involving diabetic patients for three months, showing an authoritative effect on stabilizing and controlling sugar.
Our national invention patent employs a specific processing technology that modifies the structure of the raw materials to inhibit rapid glucose absorption in the digestive tract.
Absolutely. Due to the high dietary fiber content from konjac and buckwheat, they provide high satiety, allowing you to feel full with fewer calories.
Yes, the GI value of 42.7 is verified by the Beijing Institute of Nutrition Source, and we hold a state-issued low GI food certification certificate.
They are highly recommended for individuals with "three highs" (hypertension, hyperglycemia, hyperlipidemia), people focusing on fat reduction, and those in a sub-health state.
